Prana Biotechnology (NASDAQ: PRAN) today announced that it has received approval from the Austin Health Human Research Ethics Committee (HREC) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE